-
1
-
-
34547739471
-
Bloodless surgery in a Jehovah's Witness patient with a 12.7-kg uterine leiomyosarcoma
-
Nagarsheth NP, Shander A, Malovany R, et al. Bloodless surgery in a Jehovah's Witness patient with a 12.7-kg uterine leiomyosarcoma. J Surg Educ 2007; 64: 212-219.
-
(2007)
J Surg Educ
, vol.64
, pp. 212-219
-
-
Nagarsheth, N.P.1
Shander, A.2
Malovany, R.3
-
2
-
-
0037406140
-
Bloodless medicine: Clinical care without allogeneic blood transfusion
-
Goodnough LT, Shander A, Spence R. Bloodless medicine: clinical care without allogeneic blood transfusion. Transfusion 2003; 43: 668-676.
-
(2003)
Transfusion
, vol.43
, pp. 668-676
-
-
Goodnough, L.T.1
Shander, A.2
Spence, R.3
-
3
-
-
0033015667
-
Bloodless surgery: Establishment of a program for the special medical needs of the Jehovah's Witness community-the gynecologic surgery experience at a community hospital
-
DeCastro R. Bloodless surgery: establishment of a program for the special medical needs of the Jehovah's Witness community-the gynecologic surgery experience at a community hospital. Am J Obstet Gynecol 1999; 180: 1491-1498.
-
(1999)
Am J Obstet Gynecol
, vol.180
, pp. 1491-1498
-
-
DeCastro, R.1
-
4
-
-
3843074208
-
Current status of transfusion triggers for red blood cell concentrates
-
Hardy JF. Current status of transfusion triggers for red blood cell concentrates. Transfus Apher Sci 2004; 31: 55-66.
-
(2004)
Transfus Apher Sci
, vol.31
, pp. 55-66
-
-
Hardy, J.F.1
-
5
-
-
34548802327
-
Blood transfusion in critically ill patients: State of the art
-
Hajjar LA, Auler Junior JO, Santos L, Galas F. Blood transfusion in critically ill patients: state of the art. Clinics 2007; 62: 507-524.
-
(2007)
Clinics
, vol.62
, pp. 507-524
-
-
Hajjar, L.A.1
Auler Junior, J.O.2
Santos, L.3
Galas, F.4
-
6
-
-
0018580135
-
A study of blood utilization by diagnosis, month of transfusion, and geographic region of the United States
-
Friedman BA, Burns TL, Schork MA. A study of blood utilization by diagnosis, month of transfusion, and geographic region of the United States. Transfusion 1979; 19: 511-525.
-
(1979)
Transfusion
, vol.19
, pp. 511-525
-
-
Friedman, B.A.1
Burns, T.L.2
Schork, M.A.3
-
7
-
-
73349096502
-
-
April 2007. Available at:, Accessed September 2009
-
American Association of Blood Banks. Transfusiontransmitted diseases, April 2007. Available at: http:// www.aabb.org. Accessed September 2009.
-
Transfusiontransmitted diseases
-
-
-
8
-
-
0036796878
-
Impact of allogeneic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient
-
Taylor RW, Manganaro L, O'Brien J, et al. Impact of allogeneic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med 2002; 30: 2249-2254.
-
(2002)
Crit Care Med
, vol.30
, pp. 2249-2254
-
-
Taylor, R.W.1
Manganaro, L.2
O'Brien, J.3
-
9
-
-
0036146324
-
Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery
-
Chelemer SB, Prato BS, Cox PM, et al. Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg 2002; 73: 138-142.
-
(2002)
Ann Thorac Surg
, vol.73
, pp. 138-142
-
-
Chelemer, S.B.1
Prato, B.S.2
Cox, P.M.3
-
10
-
-
0033057232
-
Blood irradiation for intraoperative autotransfusion in cancer surgery: Demonstration of efficient elimination of contaminating tumor cells
-
Hansen E, Kneuchel R, Altmeppen J, Taeger K. Blood irradiation for intraoperative autotransfusion in cancer surgery: demonstration of efficient elimination of contaminating tumor cells. Transfusion 1999; 39: 608-615.
-
(1999)
Transfusion
, vol.39
, pp. 608-615
-
-
Hansen, E.1
Kneuchel, R.2
Altmeppen, J.3
Taeger, K.4
-
11
-
-
0030764431
-
Allogeneic transfusion and infection: Economic and clinical implications
-
Blumberg N. Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol 1997; 34: 34-40.
-
(1997)
Semin Hematol
, vol.34
, pp. 34-40
-
-
Blumberg, N.1
-
12
-
-
0032860471
-
Immunomodularity aspects of transfusion: A once and future risk?
-
Klein, H. Immunomodularity aspects of transfusion: a once and future risk? Anesthesiology 1999; 91: 861-865.
-
(1999)
Anesthesiology
, vol.91
, pp. 861-865
-
-
Klein, H.1
-
13
-
-
0031888193
-
Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: A meta-analysis of unconfounded studies
-
McAlister F, Clark H, Wells P, Laupacis A. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg 1998; 85: 171-178.
-
(1998)
Br J Surg
, vol.85
, pp. 171-178
-
-
McAlister, F.1
Clark, H.2
Wells, P.3
Laupacis, A.4
-
14
-
-
28044446314
-
Understanding the consequences of transfusion-related acute lung injury
-
Shander A, Popovsky, MA. Understanding the consequences of transfusion-related acute lung injury. Chest 2005; 128: 598s-604s.
-
(2005)
Chest
, vol.128
-
-
Shander, A.1
Popovsky, M.A.2
-
15
-
-
20144389119
-
Transfusionrelated acute lung injury: Definition and review
-
Toy P, Popovsky MA, Abraham E, et al. Transfusionrelated acute lung injury: definition and review. Crit Care Med 2005; 33: 721-726.
-
(2005)
Crit Care Med
, vol.33
, pp. 721-726
-
-
Toy, P.1
Popovsky, M.A.2
Abraham, E.3
-
16
-
-
36549080065
-
The pathogenesis of transfusion-related acute lung injury and how to avoid this serious adverse reaction of transfusion
-
Sachs UJ. The pathogenesis of transfusion-related acute lung injury and how to avoid this serious adverse reaction of transfusion. Transfus Apher Sci 2007; 37: 273-282.
-
(2007)
Transfus Apher Sci
, vol.37
, pp. 273-282
-
-
Sachs, U.J.1
-
17
-
-
0026713928
-
Transfusion-related lung injury: A neglected serious complication of hemotherapy
-
Popovsky MA, Chaplan HC, Moore SB. Transfusion-related lung injury: a neglected serious complication of hemotherapy. Transfusion 1992; 32: 589-592.
-
(1992)
Transfusion
, vol.32
, pp. 589-592
-
-
Popovsky, M.A.1
Chaplan, H.C.2
Moore, S.B.3
-
18
-
-
42349097915
-
Transfusion-related acute lung injury: Incidence, pathogenesis and the role of multicomponent apheresis in its prevention
-
Popovsky MA. Transfusion-related acute lung injury: incidence, pathogenesis and the role of multicomponent apheresis in its prevention. Transfus Med Hemother 2008; 35: 76-79.
-
(2008)
Transfus Med Hemother
, vol.35
, pp. 76-79
-
-
Popovsky, M.A.1
-
19
-
-
73349100562
-
Responses on advance directives by Jehovah's Witnesses on a gynecologic oncology service. Abstracts presented for the 39th annual meeting of the Society of Gynecologic Oncologists
-
Nagarsheth NP, Gupta N, Moshier E, et al. Responses on advance directives by Jehovah's Witnesses on a gynecologic oncology service. Abstracts presented for the 39th annual meeting of the Society of Gynecologic Oncologists. Gynecol Oncol 2007; 108: s1-s182.
-
(2007)
Gynecol Oncol
, vol.108
-
-
Nagarsheth, N.P.1
Gupta, N.2
Moshier, E.3
-
20
-
-
0022621669
-
Phlebotomy for diagnostic laboratory tests in adults: Pattern of use and effect on transfusion requirements
-
Smoller BR, Kruskall MS. Phlebotomy for diagnostic laboratory tests in adults: pattern of use and effect on transfusion requirements. N Engl J Med 1986; 314: 1233-1235.
-
(1986)
N Engl J Med
, vol.314
, pp. 1233-1235
-
-
Smoller, B.R.1
Kruskall, M.S.2
-
21
-
-
43249083205
-
Perioperative anaemia management: Consensus statement on the role of intravenous iron
-
Beris P, Munoz M, Garcia-Erce A, et al. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008; 100: 599-604.
-
(2008)
Br J Anaesth
, vol.100
, pp. 599-604
-
-
Beris, P.1
Munoz, M.2
Garcia-Erce, A.3
-
22
-
-
73349118345
-
-
Available at:, Accessed September 2009
-
Procrit (epoetin alfa) prescribing information. Available at: http://www.procrit.com/procrit/shared/OBI/PI/ ProcritBooklet.pdf#page=1. Accessed September 2009.
-
Procrit (epoetin alfa) prescribing information
-
-
-
23
-
-
73349089536
-
Utility and cost effectiveness of preoperative autologous blood donation in a university-based gynecologic oncology practice
-
Horowitz NS, Gibb RK, Menegakis NE, et al. Utility and cost effectiveness of preoperative autologous blood donation in a university-based gynecologic oncology practice. Gynecol Oncol 2004; 92: 1-512.
-
(2004)
Gynecol Oncol
, vol.92
, pp. 1-512
-
-
Horowitz, N.S.1
Gibb, R.K.2
Menegakis, N.E.3
-
24
-
-
4444358417
-
Use of the cell saver in oncologic surgery. Transfusion alternatives
-
́Elias D, Vaĺerie, Vaĺerie L. Use of the cell saver in oncologic surgery. Transfusion alternatives. Transfus Med 2008; 3: 25-28.
-
(2008)
Transfus Med
, vol.3
, pp. 25-28
-
-
́Elias, D.1
Vaĺerie2
Vaĺerie, L.3
-
25
-
-
0027504279
-
Beneficial effects of autologous blood transfusion on infectious complications after colorectal cancer surgery
-
Heiss MM, Mempel W, Jauch KW, et al. Beneficial effects of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993; 342: 1328-1333.
-
(1993)
Lancet
, vol.342
, pp. 1328-1333
-
-
Heiss, M.M.1
Mempel, W.2
Jauch, K.W.3
-
26
-
-
52449091375
-
A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection
-
Jarnagin WR. A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection. Ann Surg 2008; 248: 360-369.
-
(2008)
Ann Surg
, vol.248
, pp. 360-369
-
-
Jarnagin, W.R.1
-
27
-
-
0034897944
-
Effect of hemodilution on tissue perfusion and blood coagulation during radical hysterectomy
-
Santoso JT, Hannigan EV, Levine L, et al. Effect of hemodilution on tissue perfusion and blood coagulation during radical hysterectomy. Gynecol Oncol 2001; 82: 252-256.
-
(2001)
Gynecol Oncol
, vol.82
, pp. 252-256
-
-
Santoso, J.T.1
Hannigan, E.V.2
Levine, L.3
-
28
-
-
33750205007
-
Objectives and limitations of bloodless medical care
-
Shander A, Goodnough L. Objectives and limitations of bloodless medical care. Curr Opin Hematol 2006; 13: 462-470.
-
(2006)
Curr Opin Hematol
, vol.13
, pp. 462-470
-
-
Shander, A.1
Goodnough, L.2
-
29
-
-
40749088084
-
Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood
-
Munoz M, Breymann C, Garcia-Erce JA, et al. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood. Vox Sang 2008; 94: 172-183.
-
(2008)
Vox Sang
, vol.94
, pp. 172-183
-
-
Munoz, M.1
Breymann, C.2
Garcia-Erce, J.A.3
-
30
-
-
33646379367
-
Anemia and perioperative red blood cell transfusion: A matter of tolerance
-
Madjdpour C, Donat S, Richard B. Anemia and perioperative red blood cell transfusion: a matter of tolerance. Crit Care Med 2006; 34: s102-s108.
-
(2006)
Crit Care Med
, vol.34
-
-
Madjdpour, C.1
Donat, S.2
Richard, B.3
-
31
-
-
0347517730
-
Surgery without blood
-
Shander A. Surgery without blood. Crit Care Med 2003; 31: s709-s714.
-
(2003)
Crit Care Med
, vol.31
-
-
Shander, A.1
-
32
-
-
0035001676
-
Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer: Implications for use in gynecologic surgery
-
Stovall TG. Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer: implications for use in gynecologic surgery. J Reprod Med 2001; 46: 531-538.
-
(2001)
J Reprod Med
, vol.46
, pp. 531-538
-
-
Stovall, T.G.1
-
33
-
-
40749107443
-
Weekly epoetin beta maintains haemoglobin levels and improves quality of life in patients with non-myeloid malignancies receiving chemotherapy
-
Suzuki Y, Tokuda Y, Fujiwara Y, et al. Weekly epoetin beta maintains haemoglobin levels and improves quality of life in patients with non-myeloid malignancies receiving chemotherapy. Jpn J Clin Oncol 2008; 38: 214-221.
-
(2008)
Jpn J Clin Oncol
, vol.38
, pp. 214-221
-
-
Suzuki, Y.1
Tokuda, Y.2
Fujiwara, Y.3
-
34
-
-
37849003198
-
Use of epoetin and darbopoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update
-
Rizzo JD, Somerfield MR, Hagerty KL, et al. Use of epoetin and darbopoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol 2008; 26: 132-149.
-
(2008)
J Clin Oncol
, vol.26
, pp. 132-149
-
-
Rizzo, J.D.1
Somerfield, M.R.2
Hagerty, K.L.3
-
35
-
-
50349088773
-
Continuing reassessment of the risks of erythropoiesis-stimulating agents in patients with cancer
-
Juneja V, Keegan P, Gootenberg JE, et al. Continuing reassessment of the risks of erythropoiesis-stimulating agents in patients with cancer. Clin Cancer Res 2008; 14: 3242-3247.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 3242-3247
-
-
Juneja, V.1
Keegan, P.2
Gootenberg, J.E.3
-
36
-
-
34547800459
-
Feasibility of bloodless surgery on a gynecologic oncology service
-
Nagarsheth NP, Gupta A, Gretz HF, et al. Feasibility of bloodless surgery on a gynecologic oncology service. Int J Gynecol Cancer 2006; 16: 624-694.
-
(2006)
Int J Gynecol Cancer
, vol.16
, pp. 624-694
-
-
Nagarsheth, N.P.1
Gupta, A.2
Gretz, H.F.3
-
37
-
-
73349123058
-
-
Epogen (epoetin alfa): FDA complete response and safety labeling change order: July 30, 2008. Available at: http://www.accessdata.fda.gov/drugsatfda docs/label/ 2008/103234s5195sPI.pdf. Accessed September 2009.
-
Epogen (epoetin alfa): FDA complete response and safety labeling change order: July 30, 2008. Available at: http://www.accessdata.fda.gov/drugsatfda docs/label/ 2008/103234s5195sPI.pdf. Accessed September 2009.
-
-
-
-
38
-
-
70350464531
-
Blood salvage use in gynecologic oncology
-
doi://10.1111/j.1537-2995.2009.02256. x. Available at
-
Nagarsheth, NP, Sharma T, Shander A, Awan A. Blood salvage use in gynecologic oncology. Transfusion. doi://10.1111/j.1537-2995.2009.02256. x. Available at: http://www3.interscience.wiley.com.
-
Transfusion
-
-
Nagarsheth, N.P.1
Sharma, T.2
Shander, A.3
Awan, A.4
|